Larvol Delta - Clinical-Evaluation-of-Aptinyxs-NYX783-for-Treatment-of-Opioid-Use-Disorder-to-Be-Funded-by-56-Million-NIH-Grant

NYX-783 - Aptinyx

https://www.businesswire.com/news/home/20221103005493/en/Clinical-Evaluation-of-Aptinyxs-NYX-783-for-Treatment-of-Opioid-Use-Disorder-to-Be-Funded-by-5.6-Million-NIH-Grant

Nov 3, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next